Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing Journal Article


Authors: Kopelman, J.; Budnick, A. S.; Sessions, R. B.; Kramer, M. B.; Wong, G. Y.
Article Title: Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing
Abstract: Our Institution undertook a phase I trial to define the toxicity of high-dose (150 to 225 mg) bolus administration (every 3 to 4 weeks) of cisplatin in patients with advanced cancers. All patients reported had baseline normal hearing. Hearing levels were measured prior to each course of chemotberapy. Audiological monitoring included conventional assessment of pure tone sensitivity at 500 to 8,000 Hz and assessment of ultra high frequencies (9,000 to 20,000 Hz). After one to two doses, 100% of patients faUed to respond at 9,000 Hz and above. In the 2,000 to 8,000 Hz range, repeated administration of the drug effected successively lower frequencies with progressive loss, until a maximum threshold shift or plateau was reached at each frequency between 3,000 and 8,000 Hz. The plateau for cisplatin ototoxicity appears to fall within the moderate hearing loss range (40 to 60 dB HL) in the high frequencies. AU patients complained of tinnitus and difficulty understanding speech in the presence of background noise. The pattern of pure tone audiometric alteration is consistent in all patients, all dosages, and each method of administration. The ultra high frequency alteration is prompt and dramatic. © The American Laryngological, Rhinological and Otological Society, Inc.
Keywords: adult; cancer chemotherapy; clinical article; cisplatin; neoplasms; drug administration schedule; hearing; hearing loss; intravenous drug administration; ototoxicity; middle age; audiometry; complication; drug evaluation; human; male; female; priority journal; hearing loss, bilateral; auditory threshold shift
Journal Title: Laryngoscope
Volume: 98
Issue: 8
ISSN: 0023-852X
Publisher: Wiley Blackwell  
Date Published: 1988-01-01
Start Page: 858
End Page: 864
Language: English
DOI: 10.1288/00005537-198808000-00014
PUBMED: 3398663
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 6 August 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Amy S Budnick
    19 Budnick
  2. George Y. Wong
    89 Wong